| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b76a01728ea47f5e574b71ce6e73da |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3675 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3458 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c3363a475cc08248ac5874f2a68b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886d2e3a22c5a60f24923e4b239ef891 |
| publicationDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7186420-B2 |
| titleOfInvention |
Multi-part substitution infusion fluids and matching anticoagulants |
| abstract |
A multi-part substitution infusion fluid for an extracorporeal blood treatment and methods for using same are provided. Generally, the multi-part substitution fluid comprises a first solution composed of electrolites but without divalent cations and a second solution comprising divalent cations. Another embodiment includes a third solution comprising a matching citrate/citric acid anticoagulant. The described methods of using the multi-part substitution infusion fluids significantly reduce risks associated with various extracorporeal blood treatments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8795517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8147698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012123314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7758900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007110829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211048-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8945036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008015487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7884132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9254356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010301268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134348-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011230813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158157-B2 |
| priorityDate |
1999-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |